Micro-X Limited (ASX:MX1)
0.0170
+0.0030 (21.43%)
Sep 17, 2026, 3:55 PM AEST
Micro-X Market Cap
Micro-X has a market cap or net worth of 10.53 million as of September 17, 2026. Its market cap has decreased by -83.22% in one year.
Market Cap
10.53M
Enterprise Value
13.88M
Revenue
15.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
ChartMarket Cap Chart
Since December 22, 2015, Micro-X's market cap has decreased from 71.65M to 10.53M, a decrease of -85.30%. That is a compound annual growth rate of -16.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 10.53M | -86.14% |
| Dec 31, 2025 | 76.00M | 55.15% |
| Dec 31, 2024 | 48.98M | -9.95% |
| Dec 29, 2023 | 54.40M | -18.58% |
| Dec 30, 2022 | 66.81M | -43.06% |
| Dec 31, 2021 | 117.33M | -8.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nova Eye Medical | 38.46M |
| HeraMED | 38.24M |
| OncoSil Medical | 34.19M |
| Control Bionics | 33.13M |
| CleanSpace Holdings | 30.56M |
| Memphasys | 18.52M |
| ImpediMed | 18.31M |
| CONNEQT Health | 16.30M |